Sector: Pharmaceuticals & Biotechnology

Mid Cap

Eris Lifesciences Share Price

Eris Lifesciences Ltd.

₹1,345.10

1.30(0.10%)

Invest in ERIS with up to 2.86x margin.

Trade with MTF

25th May 2026 | 10:56 AM

NSE : ERIS

Open Free Demat Account

Eris Lifesciences Performance

Price Movement

₹1345.10

₹1339.20

₹1356.90

↘ Today's Low↗ Today's High

1 Year Performance

₹1345.10

₹1200.00

₹1910.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,356.90

Low₹1,339.20

Open at₹1,344.90

Prev Close₹1,343.80

Volumes32.44 K

Avg Price₹1,346.35

Lower Circuit₹1,075.10

Upper Circuit₹1,612.50

Historical Performance

3M High₹1,495.00

3M Low₹1,200.00

1 Yr High₹1,910.00

1 Yr Low₹1,200.00

3 Yr High₹1,910.00

3 Yr Low₹605.00

5 Yr High₹1,910.00

5 Yr Low₹551.30

Eris Lifesciences Fundamentals

Market Cap

High in industry

20,205.90 Cr.

PE Ratio (TTM)

Above industry Median

32.60

Dividend Yield

Net Profit TTM

75.9% incr over last year

619.51

Net Profit Growth

75.9% incr over last year

619.51

PEG Ratio

Above industry Median

0.40

ROE

0% decr over last year

12.32

Operating Revenue TTM

3,129.42

Operating Revenue Growth

8.2% incr over last year

Book Value

Above industry Median

6.30

MFI

MFI strongly Overbought

86.03

RSI

RSI is mid-range

63.31

EPS (TTM)

25.85

Debt to Equity

0.85

Face Value

Operating Profit Margin Qtr.

34.93

Operating Profit Qtr.

273.57

Net Profit Qtr.

281.61

Operating Revenue Qtr.

756.56

PB Ratio

6.30

Eris Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	277.31	315.29	650.50	578.64	404.77
Operating Expense	255.53	237.94	353.62	362.32	283.80
Operating Profit	21.78	77.35	296.88	216.32	120.97
Depreciation	38.82	38.66	39.30	37.60	43.38
Interest	42.70	45.20	46.50	45.14	53.16
Tax	-24.17	0.80	85.10	56.27	10.71
Net Profit	-8.60	3.09	149.57	99.99	30.47

ERIS Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹1,574 - ₹0

Target Price

₹1,810

Stop Loss

Target Date

13 Nov 26

Potential Returns

14.99 %

View Call ↗

Eris Lifesciences Technicals

Eris Lifesciences Ltd. EMA & SMA

₹1345.10

8.90 (0.67%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1386

Day EMA10 ₹1374.3

Day EMA12 ₹1372.4

Day EMA20 ₹1368.6

Day EMA26 ₹1367.1

Day EMA50 ₹1371.1

Day EMA100 ₹1406.5

Day EMA200 ₹1449.4

Eris Lifesciences Support and Resistance

Resistance

First Resistance₹1522.10

Second Resistance₹1586.00

Third Resistance₹1677.00

Support

First Support₹1367.20

Second Support₹1276.20

Third Support₹1212.30

Technical Indicators

Day RSI63.31

Day MFI86.03

Day ADX20.60

Day Commodity Channel Index212.70

William-19.68

Day MACD5.33

Day MACD Signal Line1.11

Day ATR55.95

Day ROC125-5.95

Day ROC211.80

Eris Lifesciences Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	54.9	54.8	54.8	54.8	54.8	53.9
FII	8.4	8.4	8.4	7.2	6.8	6.4
DII	18	18.1	18.2	19.4	20.4	20.3
Public	18.7	18.6	18.6	18.6	18	19.3

Eris Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	22.03 K	42.99 K	51.24%
Week	52.66 K	92.58 K	56.88%
1 Month	69.8 K	1.28 L	54.44%
6 Month	56.92 K	1.26 L	45.29%

Eris Lifesciences SWOT Analysis

Strengths13

Weakness14

Opportunity3

Threats1

Positive Breakout Third Resistance ( LTP > R3)

Benjamin Graham Value Screen

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

High Volume, High Gain

Stocks in uptrend most likely to cross above SMA-200 soon

Top Gainers

High Volume, High Gain

Volume Shockers

Eris Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
13 Feb, 2025	7.35	INTERIM	13 Feb, 2025	Equity Share
11 Aug, 2022	7.35	INTERIM	16 Aug, 2022	Equity Share
05 Aug, 2021	6.01	INTERIM	06 Aug, 2021	Equity Share
13 Aug, 2020	5.5	INTERIM	14 Aug, 2020	Equity Share
19 Mar, 2020	2.87	INTERIM	20 Mar, 2020	Equity Share

Eris Lifesciences Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Senores Pharmaceuticals Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹1,699.90	₹724.95	₹953.50	₹1,145.70	₹4,689.70	₹519.30
% Change	0.91%	7.66%	0.39%	3.13%	-0.96%	-0.14%
Revenue TTM (₹ Cr)	₹1,403.18	-	₹1,598.19	₹649.50	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	₹185.12	-	₹206.20	₹115.38	₹257.90	₹255.19
PE TTM	57.20	-	78.90	43.30	43.40	31.80
1 Year Return	63.07	9.63	103.31	111.14	-2.21	-6.77
ROCE	31.54	34.78	34.76	15.60	-	11.40

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 445.35

+0.97%

CONCORDBIO

Concord Biotech Ltd.

₹ 1156.70

+0.29%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 727.80

+2.06%

SUPRIYA

Supriya Lifescience Ltd.

₹ 783.45

+1.21%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1041.50

+0.24%

COHANCE

Cohance Lifesciences Ltd.

₹ 428.75

+2.44%

SYNGENE

Syngene International Ltd.

₹ 465.80

+0.86%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 757.50

+0.24%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 226.41

+7.93%

STAR

Strides Pharma Science Ltd.

₹ 1176.60

+2.03%

GRANULES

Granules India Ltd.

₹ 760.30

+1.11%

FDC

FDC Ltd.

₹ 369.70

-0.95%

SHILPAMED

Shilpa Medicare Ltd.

₹ 510.85

+4.20%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 970.00

-3.61%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2067.00

+1.92%

MARKSANS

Marksans Pharma Ltd.

₹ 218.90

+3.32%

SANOFI

Sanofi India Ltd.

₹ 3159.40

-0.12%

PGHL

Procter & Gamble Health Ltd.

₹ 5601.00

+0.86%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 628.00

-3.35%

FAQ's on ERIS

What is the current share price of Eris Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Eris Lifesciences Ltd. is ₹ 1345.1 on the NSE and ₹ 1347.5 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Eris Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Eris Lifesciences Ltd. is approximately ₹ 20205.9 Cr.

What are the PE and PB ratios for Eris Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Eris Lifesciences Ltd. is 32.6, and the Price-to-Book (PB) ratio is 6.3.

What is the 52-Week High and Low for Eris Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Eris Lifesciences Ltd. shares was ₹ 1910, and the lowest price was ₹ 1200.

Who are the major shareholders of Eris Lifesciences Ltd.?

Significant shareholdings in Eris Lifesciences Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Eris Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Eris Lifesciences Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Eris Lifesciences Ltd.?

Eris Lifesciences Ltd. last declared a INTERIM dividend of ₹ 7.35 per share for the financial period ending 2025. The record date was set as 2025-02-13, and the payment was/is scheduled around 2025-02-13. For the most current dividend announcements, refer to official company filings.